Clinical Trial Update: Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Cabozantinib S-malate in patients with relapsed or unresectable metastatic osteosarcoma or Ewing sarcoma; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Osteosarcoma

Drugs mentioned

• Cabozantinib S-Malate (cabozantinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Ewing Sarcoma, Metastatic Osteosarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-09-04